Mayne Pharma Commrcl Drug Patent Portfolio
Mayne Pharma Commrcl owns 1 orange book drug protected by 1 US patent Given below is the list of Mayne Pharma Commrcl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6127425 | Oral liquid medicine solution | 26 Jun, 2018 | Expired |
Mayne Pharma Commrcl's Family Patents
Recent FDA approvals and tentative approvals for Mayne Pharma Commrcl
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Ethinyl Estradiol; Levonorgestrel |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 28 Apr, 2017 |
Mayne Pharma Commrcl Drug List
Given below is the complete list of Mayne Pharma Commrcl's drugs and the patents protecting them.
1. Soltamox
Soltamox is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6127425 | Oral liquid medicine solution |
26 Jun, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Soltamox's drug page